These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11824452)

  • 1. Devaluing truth: unverified health claims in the aftermath of Pearson v. Shalala.
    Vladeck DC
    Food Drug Law J; 1999; 54(4):535-53. PubMed ID: 11824452
    [No Abstract]   [Full Text] [Related]  

  • 2. Is my yogurt lying? Developing and applying a framework for determining whether wellness claims on probiotic yogurts mislead.
    Satine LA
    Food Drug Law J; 2008; 63(2):537-77. PubMed ID: 18561477
    [No Abstract]   [Full Text] [Related]  

  • 3. So you want to market a food and to make health-related claims--how far can you go? What rules of law will govern the claims you want to make?
    McNamara SH
    Food Drug Law J; 1998; 53(3):421-36. PubMed ID: 10346720
    [No Abstract]   [Full Text] [Related]  

  • 4. HHS to study ephedra, step up enforcement against illegal marketing.
    FDA Consum; 2002; 36(5):3. PubMed ID: 12412534
    [No Abstract]   [Full Text] [Related]  

  • 5. A free market for dietary supplements: issues surrounding DSHEA's exceptions to the labeling exemption for third-party literature.
    Zigler J
    Food Drug Law J; 2007; 62(1):151-63. PubMed ID: 17444029
    [No Abstract]   [Full Text] [Related]  

  • 6. Don't be starstruck by supplements. Celebrity endorsements: who's selling what.
    Consum Rep; 2012 Mar; 77(3):12. PubMed ID: 22420061
    [No Abstract]   [Full Text] [Related]  

  • 7. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E--new insights into molecular details.
    Schreier P; Humpf HU
    Mol Nutr Food Res; 2005 Jan; 49(1):1. PubMed ID: 15619260
    [No Abstract]   [Full Text] [Related]  

  • 9. New challenges for medical product promotion and its regulation.
    Pines WL
    Food Drug Law J; 1997; 52(1):61-5. PubMed ID: 10346710
    [No Abstract]   [Full Text] [Related]  

  • 10. Food labeling: nutrient content claims, expansion of the nutrient content claim "lean". Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jan; 72(8):1455-9. PubMed ID: 17294560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-OTC marketing of drugs: possible approaches.
    Mahinka SP; Bierman ME
    Food Drug Law J; 1995; 50(1):49-63. PubMed ID: 10342985
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA marketing v. First Amendment: Washington Legal Foundation legal challenges to off-label policies may force unprecedented changes at FDA.
    Kamp J; Troy DE; Alexander E
    Food Drug Law J; 1999; 54(4):555-65. PubMed ID: 11824453
    [No Abstract]   [Full Text] [Related]  

  • 13. Food labeling: health claims; soluble fiber from certain foods and risk of coronary heart disease. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 May; 73(85):23947-53. PubMed ID: 18567170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients.
    Noonan C; Patrick Noonan W
    Toxicology; 2006 Apr; 221(1):4-8. PubMed ID: 16497425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 16. The big washout.
    Czap A
    Altern Med Rev; 1999 Dec; 4(6):391. PubMed ID: 10608911
    [No Abstract]   [Full Text] [Related]  

  • 17. Food labeling: health claims; calcium and osteoporosis, and calcium, vitamin D, and osteoporosis. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Sep; 73(189):56477-87. PubMed ID: 18985959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbal Rx: the promises and pitfalls.
    Consum Rep; 1999 Mar; 64(3):44-8. PubMed ID: 10557627
    [No Abstract]   [Full Text] [Related]  

  • 19. Food labeling: health claims; soluble fiber from certain foods and risk of coronary heart disease. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(159):47828-9. PubMed ID: 18956498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DSHEA's third-party literature exemption; mail order sales, direct marketing, and Internet use.
    Raubicheck CJ
    Food Drug Law J; 1999; 54(4):587-98. PubMed ID: 11824455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.